Thermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.28, $0.03 better than the analyst estimate of $5.25. Revenue for the quarter came in at $10.6 billion versus the consensus estimate of $10.63 billion.

GUIDANCE:

Thermo Fisher Scientific sees FY2024 EPS of $21.35-$22.07, versus the consensus of $21.72. Thermo Fisher Scientific sees FY2024 revenue of $42.4-43.3 billion, versus the consensus of $42.91 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.